Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord blood transfusion in ASD
NCT04099381Phase 2Unknown
- Sponsor
- Samara Regional Medical Center Dinasty
- Start
- Aug 2019
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood mononuclear cells in Autism Spectrum Disorder (ASD), sponsored by Samara Regional Medical Center Dinasty. Status: unknown.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04099381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04099381.